Keeping immune checkpoint inhibitor myocarditis in check: advanced circulatory mechanical support as a bridge to recovery. (13th August 2021)

• Record Type: Journal Article
• Authors: Stein‐Merlob, Ashley F.; Hsu, Jeffrey J.; Colton, Bradley; Berg, Christopher J.; Ferreira, Allison; Price, Megan M.; Wainberg, Zev; Baas, Arnold S.; Deng, Mario C.; Parikh, Rushi V.; Yang, Eric H.
• Is Part Of: ESC heart failure. Volume 8:Number 5(2021)
• Page Start: 4301
• Page End: 4306
• Publication Date: 2021-08-13
• Subjects: Cardiomyopathy -- Cardiac assist device -- Acute heart failure -- Immune checkpoint inhibitor myocarditis -- Cardiooncology; Heart failure -- Periodicals; 616.129005
• DOI: 10.1002/ehf2.13545
• Languages: English
• ISSNs: 2055-5822

Abstract

Abstract: Immune checkpoint inhibitor (ICI)‐associated myocarditis is a rare, potentially life‐threatening complication of immunotherapy. We report a case of a 60‐year‐old female with a history of colorectal cancer treated with nivolumab immunotherapy who presented with new cardiomyopathy complicated by cardiogenic shock and ventricular arrhythmias. Treatment of ICI‐associated myocarditis requires aggressive immunosuppression and supportive therapy. In this case, the patient required advanced mechanical circulatory support as a bridge to recovery. This case highlights the complexity of diagnosis, haemodynamic management, and treatment of fulminant ICI myocarditis.